Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 681 of 6351
-
Could a smarter hormone schedule keep prostate cancer in check longer?
Disease control OngoingThis is a prospective single center phase IIa open label nonrandomized study, which aims to test the hypothesis that the duration of castration sensitive phase of stage IV prostate cancer can be prolonged with adaptive androgen deprivation therapy (ADT) and Docetaxel.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New eye drops aim to halt blinding disease in seniors
Disease control Recruiting nowAge-related macular degeneration (AMD) affects millions of elderly patients. When advanced, there is Geographic Atrophy (GA) in the retina. This means that there is an area with a loss of light-sensitive cells, called photoreceptors. That part of the retina can no longer see. Atr…
Phase 2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a boric acid dressing soothe Post-Birth pain and speed healing?
Symptom relief CompletedPerineal trauma, including episiotomy and first- or second-degree perineal tears, is a common postpartum condition associated with pain and delayed wound healing after vaginal birth. This randomized controlled trial aims to evaluate the effects of boric acid wet dressing on postp…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Higher chemo dose may boost survival in rare leukemia subtype
Disease control Recruiting nowLeukemia is one of the common malignant tumors that threaten human health. Although the efficacy of AML treatment has improved significantly in recent years, it remains one of the major diseases threatening human health. Current research on AML treatment mainly has two directions…
Phase 3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a psychedelic and brain zapping beat depression?
Symptom relief Recruiting nowThe purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive disorder.
Phase 2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New pill could ease psoriatic arthritis pain
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of icotrokinra (JNJ-77242113) compared to placebo in biologic-experienced and biologic-naive participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for lung cancer: targeted drug BH-30643 enters human trials
Disease control Recruiting nowThis Phase1/2, open label, multicenter study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics and preliminary anti-tumor activity of BH-30643 in patients with NSCLC having EGFR and/or HER2 mutations. Phase 1 will determine the recommended Phase 2 dos…
Phase 1/2 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug cocktail aims to stall lung cancer
Disease control OngoingThis is a Phase II, randomized, open-label, active-controlled, multicenter study to compare intravenous uliledlimab combined with sintilimab and chemotherapy versus sintilimab combined with chemotherapy in patients with previously untreated locally advanced unresectable or metast…
Phase 2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heart failure drug withdrawal trial aims to free patients from lifelong pills
Disease control Recruiting nowNew onset heart failure (HF) is observed in up to 25% of patients with incident atrial fibrillation or flutter (AF). Current guidelines suggest that both conditions (AF \& HF) be addressed with guideline directed medical therapy (GDMT) for HF and rate or rhythm control of AF. Hen…
Phase 2/3 • Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Experimental CAR-T therapy targets tough leukemia
Disease control PausedA Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Phase 1 • Sponsor: He Huang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a neck surgery slow Alzheimer's? new trial launches
Disease control By invitation onlyThe aim of this study is to evaluate the feasibility, safety, and efficacy of bilateral deep cervical lymphatic trunk decompression combined with mid and deep cervical lymph node-extracervical vein anastomosis in the treatment of patients with Alzheimer's disease. The study seeks…
Sponsor: Oriental Neurosurgery Evidence-Based-Study Team • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Poop pills and immunotherapy: a new hope for lung cancer?
Disease control Recruiting nowThis study is to determine if Healthy Donor FMT (hdFMT) improves the body's ability to fight cancer in patients with relapsed/refractory PD-L1 Positive NSCLC.
Phase 2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Promising drug duo before bladder removal shows hope for advanced cancer patients
Disease control Recruiting nowThis phase IV trial tests the impact of standard of care enfortumab vedotin and pembrolizumab followed by removal of all or part of the bladder (cytoreductive cystectomy) and/or removal of all or part of the tube that carriers urine from the kidneys to the bladder (ureterectomy) …
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for brain cancer: experimental virus therapy targets aggressive tumors
Disease control Recruiting nowThis is a multicenter, open-label study of DB107-RRV (formerly Toca 511) and DB107-FC (formerly Toca FC) when administered following surgical resection in newly diagnosed High Grade Glioma (HGG) patients. The study is designed to evaluate whether treatment with DB107-RRV in combi…
Phase 1/2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy aims to control lung cancer in First-Line patients
Disease control Recruiting nowThis is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC). This study includes two substudies (substudy A and substudy B) that will recruit participants according to histological subtypes due to differences in…
Phase 2/3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo targets resistant tumors
Disease control OngoingThe purpose of this study is to evaluate the effectiveness and safety of capivasertib + fulvestrant treatment administration in patients with locally advanced (inoperable) or metastatic HR+ / HER2- breast cancer with PIK3CA/AKT1/PTEN-altered following recurrence or progression on…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Fish oil for faster, smarter athletes? a trial puts Omega-3s to the test
Disease control Recruiting nowThe aim of this study is to evaluate the effects of omega-3 fatty acid supplementation on the Omega-3 Index, erythrocyte membrane composition, cognitive function, hormonal profile, speed, endurance performance, and hematological parameters in competitive athletes aged 16-35 years…
Sponsor: The Jerzy Kukuczka Academy of Physical Education in Katowice • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New care bundle aims to save lives after brain hemorrhage
Disease control Recruiting nowSpontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, inte…
Phase 4 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a transplant drug tame stubborn low platelets in antiphospholipid syndrome?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of sirolimus in patients with anti-phospholipid antibody-associated thrombocytopenia. In the 6-month randomized, double-blind, placebo-controlled phase, participants will receive either sirolimus 1 mg once da…
Phase 4 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Family online sessions aim to shield LGBTQ+ teens from alcohol and dating abuse
Prevention CompletedThe goal of this clinical trial is to learn about an online group program (Healthy Families Bright Futures program) for LGBTQ+ teens and their caregivers. The main question\[s\] it aims to answer are: • is this program acceptable, appropriate, and feasible for LGBTQ+ youth and th…
Sponsor: University of Colorado, Colorado Springs • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC